Novo Nordisk’s Japan Sales Log Record 89 Billion Yen on Tresiba, Victoza

Novo Nordisk Pharma President Ole Moelskov Bech Danish diabetes powerhouse Novo Nordisk A/S delivered record Japan sales of 89 billion yen in 2015, up 6% over the previous year, buoyed by its long-acting insulin analog Tresiba (insulin degludec) and Victoza...read more